Joseph P Hagan - Net Worth and Insider Trading

Joseph P Hagan Net Worth

The estimated net worth of Joseph P Hagan is at least $187,901 dollars as of 2024-04-26. Joseph P Hagan is the CEO of Regulus Therapeutics Inc and owns about 57,112 shares of Regulus Therapeutics Inc (RGLS) stock worth over $129,644. Joseph P Hagan is the Director of Aurinia Pharmaceuticals Inc and owns about 11,961 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $58,250. Joseph P Hagan is also the Sr. VP, Corporate Development of Orexigen Therapeutics Inc and owns about 1,303 shares of Orexigen Therapeutics Inc (OREXQ) stock worth over $7. Details can be seen in Joseph P Hagan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph P Hagan has not made any transactions after 2024-01-18 and currently still holds the listed stock(s).

Transaction Summary of Joseph P Hagan

To

Joseph P Hagan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph P Hagan owns 4 companies in total, including Regulus Therapeutics Inc (RGLS) , Zosano Pharma Corp (ZSANQ) , and Orexigen Therapeutics Inc (OREXQ) among others .

Click here to see the complete history of Joseph P Hagan’s form 4 insider trades.

Insider Ownership Summary of Joseph P Hagan

Ticker Comapny Transaction Date Type of Owner
RGLS Regulus Therapeutics Inc 2024-01-18 Chief Operating Officer
ZSANQ Zosano Pharma Corp 2020-06-25 director
OREXQ Orexigen Therapeutics Inc 2015-02-03 Chief Business Officer
AUPH Aurinia Pharmaceuticals Inc 2023-05-19 director

Joseph P Hagan Latest Holdings Summary

Joseph P Hagan currently owns a total of 3 stocks. Among these stocks, Joseph P Hagan owns 57,112 shares of Regulus Therapeutics Inc (RGLS) as of January 18, 2024, with a value of $129,644 and a weighting of 69%. Joseph P Hagan owns 11,961 shares of Aurinia Pharmaceuticals Inc (AUPH) as of May 19, 2023, with a value of $58,250 and a weighting of 31%. Joseph P Hagan also owns 1,303 shares of Orexigen Therapeutics Inc (OREXQ) as of September 15, 2014, with a value of $7 and a weighting of 0%.

Latest Holdings of Joseph P Hagan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RGLS Regulus Therapeutics Inc 2024-01-18 57,112 2.27 129,644
AUPH Aurinia Pharmaceuticals Inc 2023-05-19 11,961 4.87 58,250
OREXQ Orexigen Therapeutics Inc 2014-09-15 1,303 0.01 7

Holding Weightings of Joseph P Hagan


Joseph P Hagan Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph P Hagan has made a total of 14 transactions in Regulus Therapeutics Inc (RGLS) over the past 5 years, including 2 buys and 12 sells. The most-recent trade in Regulus Therapeutics Inc is the sale of 14,580 shares on January 18, 2024, which brought Joseph P Hagan around $17,350.

According to the SEC Form 4 filings, Joseph P Hagan has made a total of 1 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 272 shares on May 19, 2023, which brought Joseph P Hagan around $2,878.

According to the SEC Form 4 filings, Joseph P Hagan has made a total of 0 transactions in Orexigen Therapeutics Inc (OREXQ) over the past 5 years. The most-recent trade in Orexigen Therapeutics Inc is the acquisition of 500 shares on September 15, 2014, which cost Joseph P Hagan around $23,450.

Insider Trading History of Joseph P Hagan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph P Hagan Trading Performance

GuruFocus tracks the stock performance after each of Joseph P Hagan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph P Hagan is -7.64%. GuruFocus also compares Joseph P Hagan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph P Hagan within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph P Hagan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph P Hagan

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.78 -7.64 -11.74 -57.72 -49.36 -61.82
Relative Return to S&P 500(%) -10.16 -8.6 -16.66 -63.2 -60.86 -72.27

Joseph P Hagan Ownership Network

Ownership Network List of Joseph P Hagan

No Data

Ownership Network Relation of Joseph P Hagan


Joseph P Hagan Owned Company Details

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Joseph P Hagan is the Chief Operating Officer of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Financial Officer Crispina Calsada , Sr. VP & General Counsel Christopher Ray Aker , and President & Head of R & D Preston Klassen .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Joseph P Hagan made 1 insider transaction in Regulus Therapeutics Inc (RGLS) with a net sale of 14,580. Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 5,468 shares made by Christopher Ray Aker , a net sale of 5,468 shares made by Crispina Calsada ,

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regulus Therapeutics Inc Insider Transactions

No Available Data

Joseph P Hagan Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph P Hagan. You might contact Joseph P Hagan via mailing address: 3344 N. Torrey Pines Court, Suite 200, La Jolla Ca 92037.

Discussions on Joseph P Hagan

No discussions yet.